z-logo
open-access-imgOpen Access
Patient-Reported Outcomes and Experiences with Population Genetic Testing Offered Through a Primary Care Network
Author(s) -
Amy A. Lemke,
Laura M. Amendola,
Jennifer Thompson,
Henry M. Dunnenberger,
Kristine Kuchta,
Chi Wang,
Kristen Dilzell-Yu,
Peter J. Hulick
Publication year - 2021
Publication title -
genetic testing and molecular biomarkers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 47
eISSN - 1945-0265
pISSN - 1945-0257
DOI - 10.1089/gtmb.2020.0275
Subject(s) - medicine , family medicine , genetic testing , population , anxiety , primary care , psychology , clinical psychology , psychiatry , environmental health
Aims: To explore patient experiences in a large-scale primary care-based, preemptive genetic testing program. Methods: Patients who received genetic results from the initiative were invited to participate in an online survey 3 weeks postresult disclosure. A 6-month follow-up survey was sent to assess changes over time. Results: The initial survey was completed by 1646 patients, with 544 completing the 6-month follow-up survey. The following outcomes were high overall: patient-reported understanding of results (cancer: 87%; cardiac: 86%); perceived utility (75%); positive emotions (relieved: 66.8%; happy: 62.0%); family result sharing (67.6%); and satisfaction (87%), although analysis by demographic factors identified groups who may benefit from additional education and emotional support. Results-related health behaviors and discussions with providers increased over time (screening procedures 6.1% to 14.2% p  < 0.001; provider discussion 10.3% to 25.3%, p  < 0.001), and were more likely to take place for patients with positive cancer and/or cardiac results (39.8% vs. 7.6%, p  < 0.001). Forty-seven percent of patients reported insurance discrimination concerns, and most (79.4%) were not familiar with privacy and nondiscrimination laws. Concerns regarding discrimination and negative emotions decreased between the two survey time points (privacy issues 44.6% to 35.1% p  < 0.001; life insurance discrimination concerns 35.5% to 29.6%, p  = 0.001; anxiety 8.1% to 3.3%, p  < 0.001; and uncertainty 19.8% to 12.8%, p  < 0.001). These findings led to the development and integration of additional patient resources to improve program implementation. Conclusion: Our findings highlight patient experiences with and areas of need in a community-based genomic screening pilot initiative using a mixed primary care/genetics provider model to deliver precision medicine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here